Correlation Between NRx Pharmaceuticals and Biodexa Pharmaceticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NRx Pharmaceuticals and Biodexa Pharmaceticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NRx Pharmaceuticals and Biodexa Pharmaceticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NRx Pharmaceuticals and Biodexa Pharmaceticals, you can compare the effects of market volatilities on NRx Pharmaceuticals and Biodexa Pharmaceticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NRx Pharmaceuticals with a short position of Biodexa Pharmaceticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NRx Pharmaceuticals and Biodexa Pharmaceticals.

Diversification Opportunities for NRx Pharmaceuticals and Biodexa Pharmaceticals

-0.32
  Correlation Coefficient

Very good diversification

The 3 months correlation between NRx and Biodexa is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding NRx Pharmaceuticals and Biodexa Pharmaceticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biodexa Pharmaceticals and NRx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NRx Pharmaceuticals are associated (or correlated) with Biodexa Pharmaceticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biodexa Pharmaceticals has no effect on the direction of NRx Pharmaceuticals i.e., NRx Pharmaceuticals and Biodexa Pharmaceticals go up and down completely randomly.

Pair Corralation between NRx Pharmaceuticals and Biodexa Pharmaceticals

Assuming the 90 days horizon NRx Pharmaceuticals is expected to generate 1.2 times more return on investment than Biodexa Pharmaceticals. However, NRx Pharmaceuticals is 1.2 times more volatile than Biodexa Pharmaceticals. It trades about 0.13 of its potential returns per unit of risk. Biodexa Pharmaceticals is currently generating about -0.01 per unit of risk. If you would invest  4.50  in NRx Pharmaceuticals on September 30, 2024 and sell it today you would earn a total of  2.50  from holding NRx Pharmaceuticals or generate 55.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy87.5%
ValuesDaily Returns

NRx Pharmaceuticals  vs.  Biodexa Pharmaceticals

 Performance 
       Timeline  
NRx Pharmaceuticals 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in NRx Pharmaceuticals are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, NRx Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Biodexa Pharmaceticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biodexa Pharmaceticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

NRx Pharmaceuticals and Biodexa Pharmaceticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NRx Pharmaceuticals and Biodexa Pharmaceticals

The main advantage of trading using opposite NRx Pharmaceuticals and Biodexa Pharmaceticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NRx Pharmaceuticals position performs unexpectedly, Biodexa Pharmaceticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biodexa Pharmaceticals will offset losses from the drop in Biodexa Pharmaceticals' long position.
The idea behind NRx Pharmaceuticals and Biodexa Pharmaceticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities